COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

News Releases

News Releases

Date
Title
Document
June 10, 2014
BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences
PDF Version
June 9, 2014
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
PDF Version
June 6, 2014
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
PDF Version
May 8, 2014
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials
PDF Version
May 8, 2014
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
PDF Version
May 6, 2014
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy
PDF Version
April 7, 2014
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
PDF Version
April 3, 2014
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy
PDF Version
March 27, 2014
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.
PDF Version
March 14, 2014
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report
PDF Version

Investor Presentation

More information is coming soon.


Upcoming Events

BioDelivery Sciences International Investor Day
 Oct 14, 2021 at 10:30 AM EDT

Stay Connected

Stay up to date on the latest news

Get started now
October 1, 2021 /
Data provided by West LLC. Minimum 15 minutes delayed.